| Ident. | Authors (with country if any) | Title |
|---|
| 000072 (2020) |
Rakesh Awasthi [États-Unis] ; Lida Pacaud [États-Unis] ; Edward Waldron [États-Unis] ; Constantine S. Tam [Australie] ; Ulrich J Ger [Autriche] ; Peter Borchmann [Allemagne] ; Samantha Jaglowski [États-Unis] ; Stephen Ronan Foley [Canada] ; Koen Van Besien [États-Unis] ; Nina D. Wagner-Johnston [États-Unis] ; Marie José Kersten [Pays-Bas] ; Stephen J. Schuster [États-Unis] ; Gilles Salles [France] ; Richard T. Maziarz [États-Unis] ; Özlem Anak [États-Unis] ; Christopher Del Corral [États-Unis] ; Jufen Chu [États-Unis] ; Irina Gershgorin [États-Unis] ; Iulian Pruteanu-Malinici [États-Unis] ; Abhijit Chakraborty [États-Unis] ; Karen Thudium Mueller [États-Unis] ; Edmund K. Waller [États-Unis] | Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL |
| 000278 (2020) |
Dimitrios A. Pappas [États-Unis] ; Taylor Blachley [États-Unis] ; Steve Zlotnick [États-Unis] ; Jennie Best [États-Unis] ; Kelechi Emeanuru [États-Unis] ; Joel M. Kremer [États-Unis] | Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry. |
| 000616 (2019-06-12) |
Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France] | Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission |
| 000695 (2019) |
Michitaro Hayakawa [Japon] ; Keisuke Izumi [Japon] ; Misako Higashida-Konishi [Japon] ; Mari Ushikubo [Japon] ; Masako Tsukamoto [Japon] ; Kumiko Akiya [Japon] ; Kazuhiro Araki [Japon] ; Hisaji Oshima [Japon] | Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review. |
| 000913 (2019) |
Carlotta Nannini [Italie] ; Laura Niccoli [Italie] ; Stelvio Sestini [Italie] ; Iashar Laghai [Italie] ; Angela Coppola [Italie] ; Fabrizio Cantini [Oman] | Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study. |
| 000915 (2019) |
Olivier Vittecoq [France] ; Sandra Desouches [France] ; Marie Kozyreff [France] ; Julia Nicolau [France] ; Sophie Pouplin [France] ; Pascal Rottenberg [France] ; Nicolas Sens [France] ; Thierry Lequerre [France] ; Gilles Avenel [France] | Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study |
| 000925 (2019) |
Raimon Sanmarti [Espagne] ; Douglas J. Veale [Irlande (pays)] ; Emilio Martin-Mola [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Carlos González [Espagne] ; Liliana Ercole [Espagne] ; Rocío Alonso [Espagne] ; João E. Fonseca [Portugal] | Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial. |
| 000933 (2019) |
Rajeshwari Punekar ; Jeannie Choi ; Susan Boklage ; Melitza Iglesias-Rodriguez ; Kamala Nola | Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis |
| 000985 (2019) |
Vincent Chow ; Myungshin Oh ; Melissa A. Gessner ; Gary Fanjiang | Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Subjects |
| 000A68 (2019) |
Misaki Suzuki ; Satoshi Shoji ; So Miyoshi ; Sriram Krishnaswami | Model‐Based Comparison of Dose‐Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients |
| 000B82 (2019) |
Jianhua Wu ; Adam Keeley ; Christian Mallen ; Ann W. Morgan ; Mar Pujades-Rodriguez | Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England |
| 000D60 (2019) |
Guangxiao Li [République populaire de Chine] ; Weijun Chi [République populaire de Chine] ; Bingqing Bai [République populaire de Chine] ; Ying Li [République populaire de Chine] ; Tingting Wei [République populaire de Chine] ; Lingyu Fu [République populaire de Chine] | Dose–response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case–control study |
| 000D61 (2019) |
Line Uhrenholt [Danemark] ; Annette Schlemmer [Danemark] ; Ellen-Margrethe Hauge [Danemark] ; Robin Christensen [Danemark] ; Lene Dreyer [Danemark] ; Maria E. Suarez-Almazor [États-Unis] ; Salome Kristensen [Danemark] | Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) |
| 000D65 (2019) |
Nadira B. Mothojakan ; Janki Gore ; Muhammad K. Nisar | Does biologic survival depend on co-prescribed methotrexate dose in established rheumatoid arthritis? A real-world study |
| 000F23 (2019) |
Xia Feng [République populaire de Chine] ; Xizhu Xu [République populaire de Chine] ; Yanjun Shi [République populaire de Chine] ; Xuezhen Liu [République populaire de Chine] ; Huamin Liu [République populaire de Chine] ; Haifeng Hou [République populaire de Chine] ; Long Ji [République populaire de Chine] ; Yuejin Li [République populaire de Chine] ; Wei Wang [République populaire de Chine] ; Youxin Wang [République populaire de Chine] ; Dong Li [République populaire de Chine] | Body Mass Index and the Risk of Rheumatoid Arthritis: An Updated Dose-Response Meta-Analysis |
| 001183 (2018) |
Fréderic Franconieri [France] ; Samuel Deshayes [France] ; Hubert De Boysson [France] ; Salim Trad [France] ; Nicolas Martin Silva [France] ; Benjamin Terrier [France] ; Boris Bienvenu [France] ; Françoise Galateau-Sallé [France] ; Jean-François Emile [France] ; Alison C. Johnson [France] ; Achille Aouba [France] | Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment |
| 001243 (2018) |
Golam M. Khandaker [Royaume-Uni] ; Bianca P. Oltean [Royaume-Uni] ; Muzaffer Kaser [Royaume-Uni] ; Claire R M. Dibben [Royaume-Uni] ; Rajini Ramana [Royaume-Uni] ; Deepak R. Jadon [Royaume-Uni] ; Robert Dantzer [États-Unis] ; Alasdair J. Coles [Royaume-Uni] ; Glyn Lewis [Royaume-Uni] ; Peter B. Jones [Royaume-Uni] | Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. |
| 001270 (2018) |
Cem Gabay [Suisse] ; Bruno Fautrel [France] ; Jürgen Rech [Allemagne] ; François Spertini [Suisse] ; Eugen Feist [Allemagne] ; Ina Kötter [Allemagne] ; Eric Hachulla [France] ; Jacques Morel [France] ; Thierry Schaeverbeke [France] ; Mohamed A. Hamidou [France] ; Thierry Martin [France] ; Bernhard Hellmich [Allemagne] ; Peter Lamprecht [Allemagne] ; Hendrik Schulze-Koops [Allemagne] ; Delphine Sophie Courvoisier [Suisse] ; Andrew Sleight [Suisse] ; Eduardo Jorge Schiffrin [Suisse] | Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease |
| 001297 (2018) |
Giovanni Maria Rossi [Italie] ; Alessandro Mannoni [Italie] ; Gerardo Di Scala [Italie] ; Elena Silvestri [Italie] ; Rafaela Diana Cojan [Italie] ; Lorenzo Vannozzi [Italie] ; Alessandra Bettiol [Italie] ; Augusto Vaglio [Italie] ; Giacomo Emmi [Italie] | Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial. |
| 001465 (2018) |
Laurence E. Cheng ; Zahir Amoura ; Benjamin Cheah ; Falk Hiepe ; Barbara A. Sullivan ; Lei Zhou ; Gregory E. Arnold ; Wayne H. Tsuji ; Joan T. Merrill ; James B. Chung | Brief Report: A Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled, Multiple‐Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis |
| 001472 (2018) |
Mercedes Alperi-L Pez [Espagne] ; Sara Alonso-Castro [Espagne] ; Isla Morante-Bolado [Espagne] ; Rubén Queiro-Silva [Espagne] ; José Luis Riestra-Noriega [Espagne] ; Luis Arboleya [Espagne] ; Francisco Javier Ballina-García [Espagne] | Biological Dose Tapering in Daily Clinical Practice: A 10 Year Follow-up Study. |
